Kadcyla to Remain `Important Growth Driver': Roche CEO
Jan. 28 -- Cancer drug Kadcyla "will remain a very important growth driver," said Roche Holding AG Chief Executive Officer Severin Schwan in an interview with Manus Cranny on Bloomberg Television's "Countdown" from Basel. Roche, the world’s biggest seller of cancer drugs, forecast that revenue and profit will increase in 2015 after last year’s earnings missed analysts’ estimates.
Greece `Collision Course' Will Likely Hurt Euro: UBS
Yahoo to Spin Off Alibaba Stake Tax-Free
Lacrosse Coach Belichick Seeks Turnaround at Wesleyan